# Ophthalmic and Topical Dosage Form New Animal Drugs; Change of Sponsor; Diclofenac; Ivermectin Otic Suspension
> **Food and Drug Administration** · Final rule. · Published 2009-06-04 · Effective 2009-06-04 · 74 FR 26782
## Document
- **Document number:** E9-13015
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 74 FR 26782
- **CFR reference:** 21 CFR 524
- **Publication date:** 2009-06-04
- **Effective date:** 2009-06-04
- **HHS docket:** Docket No. FDA-2009-N-0665
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for diclofenac sodium cream and ivermectin otic suspension from IDEXX Pharmaceuticals, Inc., to Boehringer Ingelheim Vetmedica, Inc.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2009/06/04/E9-13015/ophthalmic-and-topical-dosage-form-new-animal-drugs-change-of-sponsor-diclofenac-ivermectin-otic)
---
*AI Analytics · CC0 1.0*